Universe Pharmaceuticals INC Shareholders' Equity
Universe Pharmaceuticals INC (UPC) had Shareholders' Equity of $56.13 billion as of 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-01-29
- 2025-09-30: Stockholders' Equity Attributable to Parent $56.13B.
- 2024-09-30: Stockholders' Equity Attributable to Parent $45.50B; Stockholders' Equity Attributable to Parent as first filed $45.50M.
- 2024-03-31: Stockholders' Equity Attributable to Parent $26.74M.
- 2023-09-30: Stockholders' Equity Attributable to Parent $27.97B; Stockholders' Equity Attributable to Parent as first filed $39.53M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-09-30 | $56.13B 20-F · filed 2026-01-29 | |
| 2024-09-30 | $45.50B 20-F · filed 2026-01-29 | $45.50M 20-F · filed 2025-04-29 |
| 2024-03-31 | $26.74M 6-K · filed 2024-09-20 | |
| 2023-09-30 | $27.97B 20-F · filed 2026-01-29 | $39.53M 20-F · filed 2024-01-30 |
| 2023-03-31 | $47.13M 6-K · filed 2024-09-20 | |
| 2022-09-30 | $35.33B 20-F · filed 2026-01-29 | $46.44M 20-F · filed 2023-02-10 |
| 2022-03-31 | $61.16M 6-K · filed 2023-08-31 | |
| 2021-09-30 | $46.99M 20-F · filed 2025-04-29 | $58.93M 20-F · filed 2022-01-31 |
| 2021-03-31 | $50.69M 6-K · filed 2022-08-16 | |
| 2020-09-30 | $20.80M 20-F · filed 2024-01-30 | |
| 2019-09-30 | $12.38M 20-F · filed 2023-02-10 | |
| 2018-09-30 | $9.68M 20-F · filed 2022-01-31 |